Method for determining maturity of multi-type crude oil based on spectrum and biomarker compound analysis
Through chromatography-mass spectrometry and fluorescence spectroscopy, a comprehensive identification of crude oil period was established, which solved the limitations of crude oil maturity judgment in the existing technology, and achieved accurate maturity judgment of multiple types of crude oil, including high-thermal evolution and mixing Identification of source crude oil.
Patent Information
- Application Number
- CN202310590860.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to accurately determine the maturity of crude oil with high thermal evolution, and cannot effectively identify crude oil from mixed sources, and its applicability is limited to specific regions and evolutionary scope.
Through chromatography-mass spectrometry analysis and fluorescence spectroscopy technology, the relationship between the absolute quantitative ratio of biomarker compounds and sterane compounds and the degree of thermal evolution is established, and combined with fluorescence spectroscopy characteristics, a comprehensive identification of crude oil periods is constructed to achieve maturity of multiple types of crude oil. Accurate judgment of degree.
Accurate maturity identification of single-source and mixed-source crude oils has been achieved, with wide applicability, and can identify low-maturity, mature and high-maturity crude oils, overcoming the limitations of the existing technology.
Smart Images

Figure CN119023823A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of oil and gas reservoir exploration, and in particular to a method for determining the maturity of multiple types of crude oil based on spectrum and biomarker compound analysis. Background Art
[0002] Oil and gas maturity is a geochemical parameter that characterizes the stage of oil and gas evolution and is an important basis for identifying the source of oil and gas. In order to accurately identify the maturity of crude oil, a variety of technologies have been developed. They mainly include biomarker compound parameter method, aromatic hydrocarbon parameter identification method and light hydrocarbon parameter identification method. Among them, the biomarker compound parameter method, aromatic hydrocarbon parameter method and light hydrocarbon parameter identification method are mainly based on the difference in stability of different isomers. As the degree of thermal evolution increases, the compound C with lower thermal stability gradually transforms to the isomer compound D with relatively higher thermal stability, and the relationship between their relative ratio C / (C+D) and crude oil maturity is established, so as to achieve effective identification of different evolution stages of crude oil. However, the above methods have their limitations in application. They are only applicable to a certain evolution range. For example, the biomarker compound parameter analysis method and the commonly used sterane isomerization parameter are only applicable to the characterization of oil and gas maturity within the range of thermal evolution less than 1.0%. Within this range, the sterane isomerization parameter has a linear relationship with the thermal evolution degree of crude oil and is an effective maturity identification parameter. When the thermal evolution degree of crude oil is higher than 1.0%, the biomarker compound sterane compound is prone to decomposition, and the ratio of its parameters is no longer correlated with the maturity of crude oil, and loses its significance for oil and gas maturity identification and cannot be used for oil and gas maturity characterization. Similarly, aromatic hydrocarbon parameters and light hydrocarbon parameters have no indicative significance at low evolution stages.
[0003] Recently, relevant geochemical researchers have developed an absolute quantitative technology for biomarker compounds. Wang Xiuhong et al., in their patent "Method for Determining Crude Oil Maturity by Using the Absolute Content of Terpanes in Crude Oil" (CN 109991675A), believe that as the degree of thermal evolution of crude oil increases, the content of biomarker compounds in crude oil shows a trend of gradually decreasing, so it can effectively characterize the degree of thermal evolution of crude oil. However, crude oil and source rocks in different regions have different initial biomarker compound contents due to differences in their sedimentary environments and parent material sources, resulting in different biomarker compound contents in source rocks and crude oil with the same degree of thermal evolution. Therefore, the relationship between the absolute content of biomarker compounds and maturity established in a certain region is difficult to apply to other regions, and the applicability of the method is relatively limited. At the same time, the formation process of oil and gas is relatively complex and lengthy, and the oil and gas generated by source rocks with different degrees of thermal evolution are prone to mixing. The above method cannot effectively identify crude oil with mixed sources of different degrees of thermal evolution.
[0004] Patent CN112666142B discloses a method for predicting the family components and maturity of a single oil inclusion, including step 1: collecting crude oil and making inclusion slices; step 2: performing high-resolution microscopic fluorescence spectrum test on crude oil and oil inclusions to obtain their main peak wavelengths; step 3: separating crude oil family components and normalizing saturated hydrocarbon and aromatic hydrocarbon components; step 4: performing gas chromatography-mass spectrometry test and analysis on saturated hydrocarbon and aromatic hydrocarbon components; step 5: determining the oil source using biological standards; step 6: establishing a fitting equation for the main peak wavelength of crude oil and the family components and maturity; step 7: substituting the main peak wavelength into the fitting equation in step 6 to obtain the family components and maturity of a single oil inclusion. This method is only for predicting the maturity of a single oil inclusion. The method of determining the oil source through chromatography and mass spectrometry has good applicability for crude oil of medium and low maturity, but is not universal for oil and gas of high maturity. At the same time, this method is not applicable to crude oil of mixed sources.
[0005] Patent CN110441270A discloses a method for identifying the type of crude oil maturity based on three-dimensional fluorescence of reservoir particles, the method comprising: collecting multiple core or cutting samples of the reservoir; washing the collected reservoir core or cutting samples with distilled water for multiple times, and drying the washed core or cutting samples; crushing the washed core or cutting samples, and screening out multiple reservoir particles; placing the reservoir particles in a clean beaker, pouring dichloromethane, and using ultrasonic vibration to vibrate the beaker for a first preset time, and then letting the beaker stand for a second preset time to collect the extract; performing three-dimensional fluorescence spectrum detection on the extract of the collected reservoir particles to obtain the three-dimensional fluorescence spectrum parameters of the extract; and identifying the type of crude oil maturity of the reservoir according to the three-dimensional fluorescence spectrum parameters of the extract. The method mainly uses fluorescence recognition to judge the maturity. The method mainly realizes the identification of crude oil maturity through fluorescence spectrum based on the changes in aromatic hydrocarbon components. However, when crude oils from different sources are mixed, the aromatic hydrocarbon components in the two crude oils change. At this time, the maturity characteristics of the two crude oils cannot be accurately described by the three-dimensional fluorescence spectroscopy method alone.
[0006] Based on the above analysis, a more accurate method for identifying crude oil maturity is still needed. Summary of the invention
[0007] To solve the above problems, the present invention provides a method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis. The method of the present invention can effectively identify crude oil from a single source and crude oil from mixed sources, and can also accurately identify the maturity of crude oil from a single source.
[0008] To achieve the above object, the present invention adopts the following technical solutions:
[0009] The present invention provides a method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, and the method includes the following steps:
[0010] Select source rock samples at different evolution stages for gas chromatography-mass spectrometry analysis and vitrinite reflectance test, and establish the relationship between the relative content C / (C + D) of biomarker compounds and the degree of thermal evolution;
[0011] Analyze and test the absolute concentration C of steranes in source rock samples at different evolution stages n ; Set the sterane concentration of immature source rock samples as C0, and establish the relationship between the absolute quantitative ratio C n / C0 of sterane compounds and the degree of thermal evolution;
[0012] Perform fluorescence spectral analysis on source rock samples at different evolution stages; establish the relationship between the relative content C / (C + D) of biomarker compounds, the absolute quantitative ratio C n / C0 of sterane compounds and the fluorescence spectral characteristics;
[0013] Establish a comprehensive identification chart for the stages of crude oil based on fluorescence spectral characteristics and sterane characteristics;
[0014] Determine the relative content C / (C + D) of biomarker compounds, the absolute quantitative ratio C n / C0 of sterane compounds and the main peak shift of the fluorescence spectrum of the sample to be tested, and project the points onto the comprehensive identification chart for the stages of crude oil to identify the maturity of the crude oil.
[0015] Furthermore, in the comprehensive identification chart for the stages of crude oil, the upper half of the vertical axis is the fluorescence spectral wavelength, and the lower half is the degree of thermal evolution of the crude oil; the left half of the horizontal axis is the absolute quantitative ratio C n / C0 of sterane compounds, and the right half is the relative content C / (C + D) of biomarker compounds;
[0016] Divide three regions of low-maturity crude oil, mature crude oil, and high-maturity crude oil in the first quadrant and the second quadrant of the comprehensive identification chart for the stages of crude oil.
[0017] Furthermore, in the low-maturity crude oil region, the main peak wavelength λ of the crude oil fluorescence spectrum is ≥ 620 nm, the relative content C / (C + D) of biomarker compounds is ≤ 0.35, and the absolute quantitative ratio C n / C0 of sterane compounds > 0.9; in the mature crude oil region, the main peak wavelength of the crude oil fluorescence spectrum is 500 nm ≤ λ < 620 nm, the relative content of biomarker compounds is 0.35 < C / (C + D) ≤ 0.55, and the absolute quantitative ratio of sterane compounds is 0.1 < C n / C0 ≤ 0.9; in the high-maturity crude oil region, the main peak wavelength λ of the crude oil fluorescence spectrum is < 500 nm, and the relative content of biomarker compounds is 0.35 < C / (C + D) ≤ 0.55; the absolute quantitative ratio C of sterane compounds n / C0 ≤ 0.1.
[0018] Furthermore, the method for identifying the maturity of crude oil is as follows: if the tested sample is plotted in the same maturity region in the first quadrant and the second quadrant of the comprehensive discrimination chart of crude oil stages, the maturity of the crude oil is determined according to the region where it is located;
[0019] if the tested sample is plotted in different maturity regions in the first quadrant and the second quadrant of the comprehensive discrimination chart of crude oil stages, it is determined that the crude oil is of mixed origin.
[0020] Furthermore, when the tested sample is plotted in the same maturity region, if the maturity region is the low-maturity crude oil or the mature crude oil region:
[0021] According to the relationship between the relative content C / (C + D) of biomarker compounds and the degree of thermal evolution and the relationship between the absolute quantitative ratio C of sterane compounds n / C0 and the degree of thermal evolution, the degree of thermal evolution R is calculated respectively o value;
[0022] When the data error between the two is ≤ 5%, it indicates that the sample is a low-maturity or mature crude oil of single origin;
[0023] When the data error between the two is > 5%, it indicates that the sample is a low-maturity or mature crude oil of mixed origin.
[0024] Furthermore, when it is determined to be a low-maturity crude oil of single origin, the Ro value corresponding to the absolute quantitative ratio C of sterane compounds n / C0 is the final maturity of the crude oil.
[0025] Furthermore, when it is determined to be a mature crude oil of single origin, the Ro value corresponding to the relative content C / (C + D) of biomarker compounds is the final maturity of the crude oil.
[0026] Furthermore, if the tested sample is plotted in different maturity regions in the first quadrant and the second quadrant of the comprehensive discrimination chart of crude oil stages, whether there is high-maturity crude oil is judged by the main peak wavelength of the sample fluorescence spectrum, and whether there is low-maturity crude oil is determined by the relative content C / (C + D) of biomarker compounds; whether there is mature crude oil is determined by the absolute quantitative ratio C of sterane compounds n / C0.
[0027] Further, when analyzing and testing the absolute concentration of sterane in source rock samples at different evolution stages, n-hexane is used as the solution, and C is weighed 16Deuterated steranes were prepared as standard solutions.
[0028] Furthermore, when performing fluorescence analysis, the wavelength used is 200nm to 980nm.
[0029] Compared with the prior art, the present invention has the following advantages:
[0030] The biomarker compound parameter method adopted in the present invention can realize the judgment of the maturity of multiple types of crude oils and can accurately identify low-maturity crude oil and mature crude oil from a single source.
[0031] The comprehensive identification method established by the present invention can not only realize accurate identification of crude oil from a single source, but also realize accurate identification of crude oil from mixed sources. The method of the present invention has wide applicability. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 The present invention is a flow chart of the method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis.
[0033] Figure 2 This is the comprehensive identification chart of oil and gas maturity described in the embodiment of the present invention, I: low maturity crude oil; II: mature crude oil; III: high maturity crude oil. DETAILED DESCRIPTION
[0034] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0035] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and "including" are used in this specification, they indicate the presence of features, steps, operations and combinations thereof.
[0036] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0037] Relative content of biomarker compounds C / (C+D): C represents 24-ethyl, 5α, 14α, 17α-C29, cholestane (20S); D represents 24-ethyl, 5α, 14α, 17α-C29, cholestane (20R).
[0038] The chromatography-mass spectrometry analysis method described in the following examples is as follows: the temperature of the vaporization chamber is adjusted to 300°C, the heating program is as follows: the initial temperature of the chromatographic column is 60°C, the temperature is maintained for 2 minutes, the heating rate is 4°C / min, the final temperature of the chromatographic column is 300°C, and the temperature is maintained for 45 minutes, the chromatographic column: DB5-MS 60m×0.25mm×0.25μm; carrier gas: helium, flow rate: 1ml / min; injection mode: non-divided flow; transmission line temperature: 300°C; acquisition mode: full scan (SCAN) / selected ion scan (SIM) ion source temperature: 250°C; ionization mode: electron impact (EI); ionization voltage: 70eV.
[0039] Example 1
[0040] A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, the method comprising the following steps:
[0041] Step 1. Select source rock samples at different evolution stages for chromatography-mass spectrometry analysis and vitrinite reflectance test to establish the relationship between the relative content of biomarker compounds C / (C+D) and the degree of thermal evolution;
[0042] Step 2. Analyze and test the absolute concentration of steranes in source rock samples at different evolutionary stages. n ; Set the sterane concentration of immature source rock samples as C0, and establish the absolute quantitative ratio of sterane compounds C n The relationship between / C0 and the degree of thermal evolution;
[0043] Before the test, take n-hexane as the solution, weigh C16 deuterated sterane to prepare a standard solution, weigh a certain amount of crude oil, add 50 μL of the standard solution, and add n-hexane again to make the volume to 1 mL. Centrifuge the solution to remove the residue, and put the centrifuged solution into the chromatograph for analysis and detection.
[0044] Step 3. Perform fluorescence spectroscopy analysis on source rock samples at different evolutionary stages; establish the relative content of biomarker compounds C / (C+D) and the absolute quantitative ratio of sterane compounds C n The relationship between / C0 and fluorescence spectral characteristics;
[0045] The fluorescence analysis wavelength is 200nm~980nm.
[0046] Step 4. Establish a crude oil stage comprehensive identification chart based on fluorescence spectrum characteristics and sterane characteristics; divide the first quadrant and the second quadrant of the crude oil stage comprehensive identification chart into three areas: low-maturity crude oil, mature crude oil and high-maturity crude oil.
[0047] In the low-maturity crude oil region, the main peak wavelength λ of the crude oil fluorescence spectrum is λ≥620nm, the relative content of biomarker compounds C / (C+D)≤0.35, and the absolute quantitative ratio of sterane compounds C n / C0>0.9; in the mature crude oil region, the main peak wavelength of the crude oil fluorescence spectrum is 500nm≤λ<620nm, the relative content of biomarker compounds is 0.35<C / (C+D)≤0.55, and the absolute quantitative ratio of sterane compounds is 0.1<C n / C0≤0.9; in the high-maturity crude oil region, the main peak wavelength of the crude oil fluorescence spectrum is λ<500nm, the relative content of biomarker compounds is 0.35<C / (C+D)≤0.55; the absolute quantitative ratio of sterane compounds C n / C0≤0.1.
[0048] Step 5. Perform geochemical analysis on the crude oil sample 1 to be tested, and calculate that the relative content of biomarker compounds C / (C+D) is 0.31, the absolute quantitative ratio of sterane compounds C n / C0 is 0.95, and the main peak shift of the fluorescence spectrum is 670nm.
[0049] As Figure 2 shown, the crude oil sample 1 falls into the area I in the first and second quadrants of the discrimination chart, and the sample is preliminarily identified as low-maturity crude oil;
[0050] Based on the data of the crude oil sample 1, according to the relationship between the relative content of biomarker compounds C / (C+D) and the thermal evolution degree established in step 1 and the relationship between the absolute quantitative ratio of sterane compounds C n / C0 and the thermal evolution degree established in step 2, calculate its R o parameters in the third and fourth quadrants respectively. The absolute quantitative ratio of sterane compounds C n / C0 is 0.95, and the corresponding R o value is 0.4. The relative content of biomarker compounds C / (C+D) is 0.31, and its R o value is about 0.42; the data error between the two is less than 5%, indicating that the sample is low-maturity crude oil from a single source;
[0051] In the low-maturity stage, the formula for calculating Ro based on the absolute quantitative ratio of sterane compounds C n / C0 is Ro=-2(C n / C0)+2.3; the formula for calculating Ro based on the relative content of biomarker compounds C / (C+D) is Ro=2C / (C+D)-0.2
[0052] For low-maturity crude oil, the Ro value corresponding to C n / C0 is taken as the final crude oil maturity result.
[0053] Example 2
[0054] A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, the method comprising the following steps:
[0055] Step 1 to step 4 are the same as in Example 1;
[0056] Step 5: geochemically analyze the crude oil sample 2 to be tested, and calculate the relative content of biomarker compounds C / (C+D) to be 0.54, the absolute quantitative ratio of sterane compounds C n / C0 is 0.45, and the main peak shift of the fluorescence spectrum is 550nm.
[0057] like Figure 2 As shown, crude oil sample 2 falls into region II in the first and second quadrants of the identification chart, and the basic identification sample is mature crude oil;
[0058] Based on the data of crude oil sample 2, according to the relationship between the relative content C / (C+D) of biomarker compounds and the degree of thermal evolution established in step 1 and the absolute quantitative ratio C of sterane compounds established in step 2, n The relationship between / C0 and the degree of thermal evolution is calculated in the third and fourth quadrants. o parameter:
[0059] In the mature stage, according to the concentration ratio of sterane compounds C n / C0 The formula for calculating Ro is Ro = -0.5 (C n / C0)+0.95, the formula for calculating Ro based on the isomerization parameter of C / (C+D) is Ro=2C / (C+D)-0.2.
[0060] Absolute quantitative ratio of sterane compounds C n / C0 is 0.54, and its corresponding R o The value is 0.68. According to the relative content of biomarker compounds C / (C+D) is 0.45, its R o The value is about 0.70. The error between the two data is less than 5%, indicating that the sample is mature crude oil from a single source.
[0061] For mature crude oil, the Ro value corresponding to the relative content of biomarker compounds C / (C+D) is the final crude oil maturity result. o The value is about 0.70.
[0062] Example 3
[0063] A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, the method comprising the following steps:
[0064] Step 1 to step 4 are the same as in Example 1;
[0065] Step 5. Perform geochemical analysis on the crude oil sample 3 to calculate the relative content of biomarker compounds C / (C+D) as 0.47 and the absolute quantitative ratio of sterane compounds C n / C0 is 0.05, and the main peak shift of the fluorescence spectrum is 480nm.
[0066] like Figure 2 As shown, crude oil sample 3 falls into region II in the first and second quadrants of the identification plate, and the sample is identified as high-maturity crude oil.
[0067] Example 4
[0068] A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, the method comprising the following steps:
[0069] Step 1 to step 4 are the same as in Example 1;
[0070] Step 5. Perform geochemical analysis on the crude oil samples 4 to calculate the relative content of biomarker compounds C / (C+D) and the absolute quantitative ratio of sterane compounds C n / C0 and the main peak shift of fluorescence spectrum.
[0071] Project the above three parameters to the crude oil period comprehensive identification chart;
[0072] like Figure 2 As shown, the sample point is within the different maturity areas marked on the identification plate, indicating that the crude oil is from mixed sources;
[0073] The main peak wavelength of the fluorescence spectrum of this sample is relatively high, with the main peak wavelength of the fluorescence spectrum being 580nm<λ<640nm, indicating that the overall evolution degree is low and there is no interference from highly evolved oil and gas;
[0074] At the same time, the relative content of its biomarker compounds C / (C+D) is obviously in the low evolution degree area, and the absolute quantitative ratio of its sterane compounds C n / C0 is in the maturity area as a whole. Comprehensive identification shows that the crude oil in sample 4 is a mixture of low-maturity crude oil and mature crude oil.
[0075] Example 5
[0076] A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, the method comprising the following steps:
[0077] Step 1 to step 4 are the same as in Example 1;
[0078] Step 5. Perform geochemical analysis on the crude oil samples 5 to calculate the relative content of biomarker compounds C / (C+D) and the absolute quantitative ratio of sterane compounds C n / C0 and the main peak shift of fluorescence spectrum.
[0079] Project the above three parameters to the crude oil period comprehensive identification chart; Figure 2 As shown, the sample point is within the different maturity areas marked on the identification plate, indicating that the crude oil is from mixed sources;
[0080] The main peak wavelength of the fluorescence spectrum of this sample is relatively low, and the main peak wavelength of the fluorescence spectrum is 490nm<λ<540nm, indicating that there is high-maturity crude oil in the crude oil.
[0081] Judging by the relative content of biomarker compounds C / (C+D), the crude oil is generally in the mature and high-mature crude oil zone, indicating that there is no low-evolution crude oil mixed in the crude oil.
[0082] Absolute quantification of sterane compounds by C n / C0 identification, C n / C0>0.1 indicates that the crude oil sample contains mature crude oil;
[0083] Comprehensive identification shows that the crude oil in sample 5 is a mixture of mature oil and gas and highly mature oil and gas.
[0084] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A method for determining the maturity of multiple types of crude oil based on spectral and biomarker compound analysis, It is characterized in that The following steps are involved: Source rock samples at different evolutionary stages were selected for chromatography-mass spectrometry analysis and vitrinite reflectance test to establish the relationship between the relative content of biomarker compounds C / (C+D) and the degree of thermal evolution; the absolute quantitative ratio of sterane compounds C n / C 0 Relationship with the degree of thermal evolution; Establish the relative content of biomarker compounds C / (C+D) and the absolute quantitative ratio of sterane compounds C n / C 0 Relationship with fluorescence spectral characteristics; Establish a comprehensive identification chart for crude oil stages based on fluorescence spectrum characteristics and sterane characteristics; Determine the relative content of biomarker compounds C / (C+D) and the absolute quantitative ratio of sterane compounds C n / C 0 The main peak shift of the fluorescence spectrum is calculated and projected onto the crude oil period comprehensive identification chart to identify the crude oil maturity.
2. The method according to claim 1, It is characterized in that The crude oil phase comprehensive identification chart has the upper half of the vertical axis representing the fluorescence spectrum wavelength, the lower half representing the thermal evolution degree of crude oil, and the left half of the horizontal axis representing the absolute quantitative ratio C of sterane compounds. n / C 0 , the right half axis is the relative content of biomarker compounds C / (C+D); The first quadrant and the second quadrant of the crude oil stage comprehensive identification chart are respectively divided into three areas: low-maturity crude oil, mature crude oil and high-maturity crude oil.
3. The method according to claim 2, It is characterized in that In the low-maturity crude oil region, the main peak wavelength λ of the crude oil fluorescence spectrum satisfies λ≥620nm, the relative content of biomarker compounds C / (C + D)≤0.35, and the absolute quantitative ratio of sterane compounds C n / C 0 >0.9; in the mature crude oil region, the main peak wavelength of the crude oil fluorescence spectrum satisfies 500nm≤λ<620nm, the relative content of biomarker compounds 0.35<C / (C + D)≤0.55, and the absolute quantitative ratio of sterane compounds 0.1<C n / C 0 ≤0.9; in the high-maturity crude oil region, the main peak wavelength of the crude oil fluorescence spectrum satisfies λ<500nm, the relative content of biomarker compounds 0.35<C / (C + D)≤0.55; the absolute quantitative ratio of sterane compounds C n / C 0 ≤0.
1.
4. The method according to claim 2, It is characterized in that The method for identifying the maturity of crude oil is as follows: if the sample to be tested is placed in the same maturity area in the first quadrant and the second quadrant of the crude oil period comprehensive identification chart, the maturity of the crude oil is determined according to the area where it is located; If the sample to be tested is projected into different maturity areas in the first and second quadrants of the crude oil period comprehensive identification chart, the crude oil is determined to be a mixed source crude oil.
5. The method according to claim 4, It is characterized in that When the samples to be tested are placed in the same maturity region, if the maturity region is a low-maturity crude oil or a mature crude oil region: According to the relationship between the relative content of biomarker compounds C / (C+D) and the degree of thermal evolution and the absolute quantitative ratio of sterane compounds C n / C 0 The relationship between the thermal evolution degree and the thermal evolution degree R o value; When the error between the two data is ≤5%, it indicates that the sample is low-maturity or mature crude oil from a single source; When the error between the two data is greater than 5%, it indicates that the sample is low-maturity or mature crude oil from mixed sources.
6. The method according to claim 5, It is characterized in that When it is determined to be a low-maturity crude oil from a single source, the absolute quantitative ratio of sterane compounds C n / C 0 The corresponding Ro value is the final crude oil maturity.
7. The method according to claim 5, It is characterized in that When it is determined to be mature crude oil from a single source, the Ro value corresponding to the relative content of biomarker compounds C / (C+D) is the final maturity of the crude oil.
8. The method according to claim 4, It is characterized in that If the sample to be tested is projected into the different maturity areas in the first and second quadrants of the crude oil phase comprehensive identification chart, the main peak wavelength of the sample fluorescence spectrum is used to determine whether there is high-maturity crude oil, and the relative content of biomarker compounds C / (C+D) is used to determine whether there is low-maturity crude oil; the absolute quantitative ratio of sterane compounds C n / C 0 Determine whether there is mature crude oil.
9. The method according to claim 1, It is characterized in that When analyzing the absolute concentration of sterane in source rock samples at different evolutionary stages, n-hexane was used as the solution and C 16 Deuterated steranes were prepared as standard solutions.
10. The method according to claim 1, It is characterized in that When performing fluorescence analysis, the wavelength used is 200nm~980nm.
